GeneBioTech Co. Ltd Capital Reinvestment Ratio
GeneBioTech Co. Ltd capital reinvestment ratio. GeneBioTech Co. Ltd (086060) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩2.15 Billion) in capital expenditures (₩96.62 Million). Check GeneBioTech Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of GeneBioTech Co. Ltd (2009–2025)
Capital reinvestment ratio of GeneBioTech Co. Ltd from 2009 to 2025. This chart tracks GeneBioTech Co. Ltd's Capital Reinvestment Ratio across 12 annual periods. Also explore net asset momentum of GeneBioTech Co. Ltd to track the company's year-over-year net asset growth rate.
GeneBioTech Co. Ltd Capital Reinvestment Ratio by Year (2009–2025)
GeneBioTech Co. Ltd capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see how efficiently does GeneBioTech Co. Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | ₩7.61 Billion | ₩3.76 Billion | ▲ +374.4% |
| 2023 | 0.10x | ₩7.37 Billion | ₩766.93 Million | ▼ -94.1% |
| 2020 | 1.76x | ₩2.49 Billion | ₩4.39 Billion | ▲ +1777.2% |
| 2018 | 0.09x | ₩5.96 Billion | ₩558.47 Million | ▼ -90.4% |
| 2017 | 0.98x | ₩1.13 Billion | ₩1.11 Billion | ▲ +300.8% |
| 2016 | 0.24x | ₩5.31 Billion | ₩1.30 Billion | ▼ -31.5% |
| 2015 | 0.36x | ₩2.61 Billion | ₩927.06 Million | ▲ +50.2% |
| 2014 | 0.24x | ₩2.15 Billion | ₩510.55 Million | ▼ -3.2% |
| 2013 | 0.24x | ₩2.38 Billion | ₩582.01 Million | ▼ -75.4% |
| 2011 | 0.99x | ₩2.53 Billion | ₩2.51 Billion | ▲ +66.9% |
| 2010 | 0.60x | ₩1.17 Billion | ₩693.45 Million | ▲ +593.8% |
| 2009 | 0.09x | ₩2.68 Billion | ₩229.99 Million | — |